down arrow

Amrutanjan Healt

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE098F01031
  • NSEID: AMRUTANJAN
  • BSEID: 590006
INR
635.55
1.85 (0.29%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.93 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

632.80666.50

52 Week

548.05861.40
Valuation
Technical
Day's Volume

CASH

3.93 k (-67.94%) Volume

Shareholding (Dec 2024)

FII

2.30%

Held by 26 FIIs

DII

11.12%

Held by 10 DIIs

Promoter

46.52%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROE of 19.83%

 
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Poor long term growth as Net Sales has grown by an annual rate of 9.01% and Operating profit at 7.01% over the last 5 years

 
4

Positive results in Dec 24

5

Stock is technically in a Mildly Bearish range

6

With ROE of 16.6, it has a Attractive valuation with a 6.2 Price to Book Value

7

Majority shareholders : Promoters

 
8

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 1,837 Cr (Small Cap)

stock-summary
P/E

37.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.73%

stock-summary
Debt Equity

-0.24

stock-summary
Return on Equity

16.57%

stock-summary
Price to Book

6.15

Revenue and Profits (1 Year):
Net Sales:
123 Cr
(Quarterly Results - Dec 2024)
Net Profit:
19 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.73%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-18.31%
0.28%
-18.03%
1 Year
-5.31%
0.58%
-4.73%
2 Years
4.36%
1.56%
5.92%
3 Years
-29.1%
1.75%
-27.35%
4 Years
6.28%
2.54%
8.82%
5 Years
69.5%
6.03%
75.53%

Latest dividend: 1 per share ex-dividend date: Feb-18-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
9.01%
EBIT Growth (5y)
7.01%
EBIT to Interest (avg)
55.07
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.52
Tax Ratio
27.34%
Dividend Payout Ratio
29.57%
Pledged Shares
0
Institutional Holding
13.42%
ROCE (avg)
39.74%
ROE (avg)
19.83%
Valuation key factors
Factor
Value
P/E Ratio
37
Industry P/E
33
Price to Book Value
6.15
EV to EBIT
35.01
EV to EBITDA
31.04
EV to Capital Employed
7.77
EV to Sales
3.97
PEG Ratio
2.79
Dividend Yield
0.73%
ROCE (Latest)
21.46%
ROE (Latest)
16.57%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 5 Schemes (9.21%)

FIIs

Held by 26 FIIs (2.3%)

Promoter with highest holding

Goodhealth Holdings Private Limited (20.15%)

Highest Public shareholder

Dsp Small Cap Fund (5.07%)

Individual Investors Holdings

33.73%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 4.92% vs 19.81% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 10.32% vs 62.93% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "122.75",
          "val2": "116.99",
          "chgp": "4.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.34",
          "val2": "21.57",
          "chgp": "8.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.06",
          "val2": "0.05",
          "chgp": "20.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "19.25",
          "val2": "17.45",
          "chgp": "10.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.01%",
          "val2": "18.44%",
          "chgp": "0.57%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 9.30% vs -2.48% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 18.40% vs -15.64% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "193.65",
          "val2": "177.17",
          "chgp": "9.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.15",
          "val2": "14.00",
          "chgp": "22.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.12",
          "val2": "0.05",
          "chgp": "140.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "16.41",
          "val2": "13.86",
          "chgp": "18.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.86%",
          "val2": "7.90%",
          "chgp": "0.96%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 7.56% vs 5.31% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 13.89% vs 15.36% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "316.40",
          "val2": "294.16",
          "chgp": "7.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "40.49",
          "val2": "35.57",
          "chgp": "13.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.18",
          "val2": "0.10",
          "chgp": "80.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "35.66",
          "val2": "31.31",
          "chgp": "13.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.80%",
          "val2": "12.09%",
          "chgp": "0.71%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 10.96% vs -6.46% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 12.90% vs -40.72% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "421.23",
          "val2": "379.64",
          "chgp": "10.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "51.81",
          "val2": "44.39",
          "chgp": "16.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.16",
          "val2": "0.08",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "44.97",
          "val2": "39.83",
          "chgp": "12.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.30%",
          "val2": "11.69%",
          "chgp": "0.61%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
122.75
116.99
4.92%
Operating Profit (PBDIT) excl Other Income
23.34
21.57
8.21%
Interest
0.06
0.05
20.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
19.25
17.45
10.32%
Operating Profit Margin (Excl OI)
19.01%
18.44%
0.57%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 4.92% vs 19.81% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 10.32% vs 62.93% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
193.65
177.17
9.30%
Operating Profit (PBDIT) excl Other Income
17.15
14.00
22.50%
Interest
0.12
0.05
140.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
16.41
13.86
18.40%
Operating Profit Margin (Excl OI)
8.86%
7.90%
0.96%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 9.30% vs -2.48% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 18.40% vs -15.64% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
316.40
294.16
7.56%
Operating Profit (PBDIT) excl Other Income
40.49
35.57
13.83%
Interest
0.18
0.10
80.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
35.66
31.31
13.89%
Operating Profit Margin (Excl OI)
12.80%
12.09%
0.71%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 7.56% vs 5.31% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 13.89% vs 15.36% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
421.23
379.64
10.96%
Operating Profit (PBDIT) excl Other Income
51.81
44.39
16.72%
Interest
0.16
0.08
100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
44.97
39.83
12.90%
Operating Profit Margin (Excl OI)
12.30%
11.69%
0.61%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 10.96% vs -6.46% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 12.90% vs -40.72% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Amrutanjan Health Care Ltd stock-summary
stock-summary
Amrutanjan Health Care Ltd
Small Cap
Pharmaceuticals & Drugs
Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu. The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research. Three plants have been set up in the Alandur industrial belt near Chennai to produce these products. It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore.
Company Coordinates stock-summary
Company Details
New 103 Old 42-45 LuzChurch Rd, Mylapore Chennai Tamil Nadu : 600004
stock-summary
Tel: 91-44-24994164/24994465/24994366
stock-summary
http://www.amrutanjan.com
stock-summary
shares@amrutanjan.com
Registrar Details
Cameo Corporate Services Ltd , Subramanian Buildings No 1 , Club House Road, Chennai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."